45 related articles for article (PubMed ID: 19168363)
1. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
[TBL] [Abstract][Full Text] [Related]
2. Dialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents.
Suryadevara PK; Racherla KK; Olepu S; Norcross NR; Tatipaka HB; Arif JA; Planer JD; Lepesheva GI; Verlinde CL; Buckner FS; Gelb MH
Bioorg Med Chem Lett; 2013 Dec; 23(23):6492-9. PubMed ID: 24120539
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Anti-Chagas Activity Profile of a Redox-Active Lead 3-Benzylmenadione Revealed by High-Content Imaging.
Trometer N; Pecourneau J; Feng L; Navarro-Huerta JA; Lazarin-Bidóia D; de Oliveira Silva Lautenschlager S; Maes L; Fortes Francisco A; Kelly JM; Meunier B; Cal M; Mäser P; Kaiser M; Davioud-Charvet E
ACS Infect Dis; 2024 May; 10(5):1808-1838. PubMed ID: 38606978
[TBL] [Abstract][Full Text] [Related]
4. Rapid syntheses of N-fused heterocycles via acyl-transfer in heteroaryl ketones.
Ye D; Lu H; He Y; Zheng Z; Wu J; Wei H
Nat Commun; 2022 Jun; 13(1):3337. PubMed ID: 35680930
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 5-amino-
Hosseini H; Bayat M
RSC Adv; 2018 Dec; 8(72):41218-41225. PubMed ID: 35559289
[TBL] [Abstract][Full Text] [Related]
6. An efficient synthesis of new imidazo[1,2-
Hosseini H; Bayat M
RSC Adv; 2019 Mar; 9(13):7218-7227. PubMed ID: 35519992
[TBL] [Abstract][Full Text] [Related]
7. Electro-organic synthesis of tetrahydroimidazo[1,2-a]pyridin-5(1H)-one via a multicomponent reaction.
Asghariganjeh MR; Mohammadi AA; Tahanpesar E; Rayatzadeh A; Makarem S
Mol Divers; 2021 Feb; 25(1):509-516. PubMed ID: 31919737
[TBL] [Abstract][Full Text] [Related]
8. Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways.
Zhang YJ; Xu ZG; Li SQ; He LJ; Tang Y; Chen ZZ; Yang DL
Cancer Cell Int; 2018; 18():90. PubMed ID: 29988358
[TBL] [Abstract][Full Text] [Related]
9. Facile construction of fused benzimidazole-isoquinolinones that induce cell-cycle arrest and apoptosis in colorectal cancer cells.
He LJ; Yang DL; Li SQ; Zhang YJ; Tang Y; Lei J; Frett B; Lin HK; Li HY; Chen ZZ; Xu ZG
Bioorg Med Chem; 2018 Aug; 26(14):3899-3908. PubMed ID: 29921474
[TBL] [Abstract][Full Text] [Related]
10. Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase.
Cerecetto H; González M
Pharmaceuticals (Basel); 2010 Mar; 3(4):810-838. PubMed ID: 27713281
[TBL] [Abstract][Full Text] [Related]
11. Facile microwave-assisted synthesis of benzimidazole scaffolds via Ugi-type three-component condensation (3CC) reactions.
Song GT; Xu ZG; Tang DY; Li SQ; Xie ZG; Zhong HL; Yang ZW; Zhu J; Zhang J; Chen ZZ
Mol Divers; 2016 May; 20(2):575-80. PubMed ID: 26577113
[TBL] [Abstract][Full Text] [Related]
12. Trypanocidal activity of thioamide-substituted imidazoquinolinone: electrochemical properties and biological effects.
Frank FM; Ciccarelli AB; Bollini M; Bruno AM; Batlle A; Lombardo ME
Evid Based Complement Alternat Med; 2013; 2013():945953. PubMed ID: 23935690
[TBL] [Abstract][Full Text] [Related]
13. Antiprotozoal activity of quinonemethide triterpenes from Maytenus ilicifolia (Celastraceae).
Dos Santos VA; Leite KM; da Costa Siqueira M; Regasini LO; Martinez I; Nogueira CT; Galuppo MK; Stolf BS; Pereira AM; Cicarelli RM; Furlan M; Graminha MA
Molecules; 2013 Jan; 18(1):1053-62. PubMed ID: 23322069
[TBL] [Abstract][Full Text] [Related]
14. A general and facile one-pot process of isothiocyanates from amines under aqueous conditions.
Sun N; Li B; Shao J; Mo W; Hu B; Shen Z; Hu X
Beilstein J Org Chem; 2012; 8():61-70. PubMed ID: 22423272
[TBL] [Abstract][Full Text] [Related]
15. Advances in Chagas disease drug development: 2009-2010.
Buckner FS; Navabi N
Curr Opin Infect Dis; 2010 Dec; 23(6):609-16. PubMed ID: 20885320
[TBL] [Abstract][Full Text] [Related]
16. Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Ancizu S; Moreno E; Torres E; Burguete A; Pérez-Silanes S; Benítez D; Villar R; Solano B; Marín A; Aldana I; Cerecetto H; González M; Monge A
Molecules; 2009 Jun; 14(6):2256-72. PubMed ID: 19553897
[TBL] [Abstract][Full Text] [Related]
17. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
[TBL] [Abstract][Full Text] [Related]
18. New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies.
Rodríguez J; Arán VJ; Boiani L; Olea-Azar C; Lavaggi ML; González M; Cerecetto H; Maya JD; Carrasco-Pozo C; Cosoy HS
Bioorg Med Chem; 2009 Dec; 17(24):8186-96. PubMed ID: 19900812
[TBL] [Abstract][Full Text] [Related]
19. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents.
Boiani M; Boiani L; Denicola A; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Vega C; Rolan M; Gómez-Barrio A; Cerecetto H; Gonzalez M
J Med Chem; 2006 Jun; 49(11):3215-24. PubMed ID: 16722639
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
